19 results
8-K
EX-99.1
ALKS
Alkermes plc
26 Jul 23
Alkermes plc Reports Second Quarter 2023 Financial Results
7:06am
reflecting acceleration in recruitment for the nemvaleukin alfa (nemvaleukin) clinical studies and investment in the ALKS 2680 phase 1 study.
oSelling
DEFC14A
ALKS
Alkermes plc
25 May 23
Proxy in contested solicitation
4:03pm
and worked with our employee resource groups to enhance our benefits and human resources policies to support recruitment and retention of diverse … that was incorporated into their respective 2022 performance objectives.
Enhanced employee benefits to support recruitment and retention of diverse talent
PRER14A
ALKS
Alkermes plc
19 May 23
Preliminary revised proxy
5:23pm
to support recruitment and retention of diverse talent.
Published our 5th Corporate Responsibility Report, disclosing our DIB initiatives, employee … objectives.
Enhanced employee benefits to support recruitment and retention of diverse talent.
Began phased Board declassification.
Appointed a new
PREC14A
j71tl hnt2oh9l7ni6
8 May 23
Preliminary proxy with contested solicitation
4:34pm
DEFC14A
bt73exbof59q4n
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
ko6ph5ei
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-99.1
u4zjrpt2576q8w
10 Dec 20
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
7:19am
8-K
EX-10.1
us5uske
10 Dec 20
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
7:19am
8-K
EX-99.2
e9c2glutkyb
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
8-K
EX-99.1
5qu0nvcvcw09fol5i1
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
8-K
EX-99.1
b5cf6llktlm31w87yak
7 Jan 19
Results of Operations and Financial Condition
7:13am
- Prev
- 1
- Next